Asgard Alcobev Reports Q2 Revenue Surge Following Pivot
Asgard Alcobev is set to draw investor attention on Monday, November 16, following the release of its second-quarter financial results for fiscal year 2027. The brewery company, which has seen a 325% return over the last four years, reported a significant uptick in performance as it continues its transition toward a brewing-led business model.
The company’s consolidated revenue from operations reached ₹48.93 crore for Q2 FY27, representing a 102.84% increase compared to the ₹24.12 crore reported in the same quarter last year. Net profit after tax (PAT) saw a substantial rise, climbing to ₹2.55 crore from ₹16.95 lakh in the prior-year period, marking a growth of 1,402.3%.
Operational metrics also showed improvement, with production rising 18.6% sequentially to 13.82 lakh cases and dispatches increasing 14% to 13.58 lakh cases. Capacity utilization reached 78.6%, up from 63.1%. Furthermore, the company reported a reduction in gross borrowings, which fell from ₹72.54 crore as of March 31, 2026, to ₹60.84 crore by the end of September.
The transition to a brewing-focused business follows the company's acquisition of a controlling stake in CMJ Breweries in February 2026. Managing Director Ronak Jain attributed the quarterly performance to enhanced manufacturing operations and improved profitability. Looking ahead, the company has set an EBITDA target of approximately ₹24-28 crore for FY27 and aims to expand its annual manufacturing capacity from 8.4 million cases to 10.8 million cases by March 2027.
The stock, which has a history of a 1:10 stock split executed in early 2025, closed at ₹35.23 on the BSE on Friday, November 13. While it has gained 8% over the past month and 17% over the last three months, the stock has declined 21% over the past year, with a 52-week high of ₹63 and a 52-week low of ₹27.21.
For investors, Asgard Alcobev’s recent results highlight the tangible impact of its strategic pivot toward brewing operations. Market participants should monitor whether the company can successfully meet its capacity expansion goals and maintain its current EBITDA trajectory, as these factors will be critical in sustaining the momentum seen in its latest quarterly performance.
Why it matters
The company's sharp rise in profitability and revenue following a strategic business transition provides a case study in how operational shifts can impact small-cap stock performance.
FAQ
What was the reason for the change in the company's business line?
The company transitioned to a brewing-led business following its acquisition of a controlling stake in CMJ Breweries in February 2026.
How did the 1:10 stock split affect shareholdings?
The split, which had a record date of January 3, 2025, converted each equity share with a face value of ₹10 into 10 shares with a face value of ₹1 each, adjusting the number of shares and price proportionately without changing the overall value of an investor's holding.
What is the company's manufacturing capacity expansion target?
Asgard Alcobev aims to increase its annual manufacturing capacity from 8.4 million cases to 10.8 million cases by March 2027.
Source: Mint Markets. See the original source for full details.
Scan with your phone
Scan with your phone